e-learning
resources
ERJ
2009
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency
Brand P., Schulte M., Wencker M., Herpich C. H., Klein G., Hanna K., Meyer T.
Source:
Eur Respir J 2009; 33: 354-360
Journal Issue:
August
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Brand P., Schulte M., Wencker M., Herpich C. H., Klein G., Hanna K., Meyer T.. Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency. Eur Respir J 2009; 33: 354-360
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Related content which might interest you:
Inhaled heparin in cystic fibrosis
Source: Eur Respir J 2006; 27: 354-358
Year: 2006
Inhibition of airway proteases in cystic fibrosis lung disease
Source: Eur Respir J 2008; 32: 783-795
Year: 2008
α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients
Source: Eur Respir J 2007; 29: 240-250
Year: 2007
Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights
Source: Eur Respir J 2009; 33: 475-488
Year: 2009
Inhaled phosphodiesterase type 5 inhibitors restore chloride transport in cystic fibrosis mice
Source: Eur Respir J 2011; 37: 72-78
Year: 2011
Long-term clearance from small airways in patients with cystic fibrosis
Source: Eur Respir J 2005; 25: 317-323
Year: 2005
Increased systemic inflammation in cystic fibrosis (CF) is associated with deterioration in lung clearance index (LCI)
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014
Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis
Source: Eur Respir J 2002; 19: 294-302
Year: 2002
Pulmonary administration of alpha
1
-antitrypsin for the treatment of Alpha
1
-antitrypsin deficiency
Source: Eur Respir J 2003; 22: Suppl. 45, 385s
Year: 2003
LATE-BREAKING ABSTRACT: A relative plasma Elafin deficiency in children with cystic fibrosis (CF) is associated with pulmonary disease
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014
SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition
Source: Eur Respir J 2011; 37: 1083-1090
Year: 2011
Alveolar nitric oxide correlates with lung volumes in patients with emphysema and Alpha-1 antitrypsin deficiency (AATD)
Source: Eur Respir J 2006; 28: Suppl. 50, 223s
Year: 2006
Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study
Source: Eur Respir J 2005; 25: 62-68
Year: 2005
The role of matrix metalloproteinases in cystic fibrosis lung disease
Source: Eur Respir J 2011; 38: 721-727
Year: 2011
Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis
Source: Eur Respir J 2011; 37: 1091-1095
Year: 2011
Clinical features of alpha one antitrypsin deficiency in non cystic fibrosis bronchiectasis
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis
Source: Eur Respir J 2002; 20: 122-126
Year: 2002
Inhalation therapy in cystic fibrosis
Source: School Course 2013 - Cystic Fibrosis
Year: 2013
Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis
Source: Eur Respir J 2001; 18: 316-322
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept